Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Posaconazole 40mg/ml oral suspension |
| BNF code | 0502010A0AAAAAA |
| Virtual Therapeutic Moiety | Posaconazole |
| Date identifier became valid | 9 May 2023 |
| Previous product identifier | 424692003 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Posaconazole |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 40.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Oral suspension |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Noxafil 40mg/ml oral suspension (Merck Sharp & Dohme (UK) Ltd) | |
| Posaconazole 40mg/ml oral suspension (A A H Pharmaceuticals Ltd) | |
| Posaconazole 40mg/ml oral suspension (Crescent Pharma Ltd) | |
| Posaconazole 40mg/ml oral suspension (Dr Reddy's Laboratories (UK) Ltd) | |
| Posaconazole 40mg/ml oral suspension (Morningside Healthcare Ltd) | |
| Posaconazole 40mg/ml oral suspension (Neon Healthcare Ltd) | |
| Posaconazole 40mg/ml oral suspension (Thornton & Ross Ltd) | |
| Virtual Medicinal Product Packs | |
| Posaconazole 40mg/ml oral suspension 105 ml | |
dm+d data retrieved from TRUD: release NHSBSA_2.2.0_20250217000001, imported on 18th February 2025 at 03:53:40.